These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6689662)

  • 1. Antivirals in chronic hepatitis B--problems of small clinical trials.
    Gregory PB
    Gastroenterology; 1984 Jan; 86(1):201-4. PubMed ID: 6689662
    [No Abstract]   [Full Text] [Related]  

  • 2. Designing clinical development programs for anti-hepatitis B virus drugs.
    Brown NA
    Methods Mol Med; 2004; 96():499-537. PubMed ID: 14762289
    [No Abstract]   [Full Text] [Related]  

  • 3. Antivirals against DNA viruses (hepatitis B and the herpes viruses).
    Hewlett G; Hallenberger S; Rübsamen-Waigmann H
    Curr Opin Pharmacol; 2004 Oct; 4(5):453-64. PubMed ID: 15351349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Navigating the maze of hepatitis B treatments.
    Lok AS
    Gastroenterology; 2007 Apr; 132(4):1586-94. PubMed ID: 17408643
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical course of four patients receiving the experimental antiviral agent fialuridine for the treatment of chronic hepatitis B infection.
    Stevenson W; Gaffey M; Ishitani M; McCullough C; Dickson R; Caldwell S; Lobo P; Pruett T
    Transplant Proc; 1995 Feb; 27(1):1219-21. PubMed ID: 7878856
    [No Abstract]   [Full Text] [Related]  

  • 6. Very few hepatitis trials recruiting.
    AIDS Patient Care STDS; 1998 Apr; 12(4):319-20. PubMed ID: 11361965
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of novel beta-L(-)-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma.
    Bridges EG; Cheng YC
    Prog Liver Dis; 1995; 13():231-45. PubMed ID: 9224504
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of catergen on the course of acute viral hepatitis].
    Babiuch L; Poznańska H; Rychalska B
    Przegl Epidemiol; 1981; 35(4):471-7. PubMed ID: 6803308
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sylimarol in the treatment of acute viral hepatitis].
    Tkacz B; Dworniak D
    Wiad Lek; 1983 Apr; 36(8):613-6. PubMed ID: 6353775
    [No Abstract]   [Full Text] [Related]  

  • 10. The mechanisms of action of antivirals against hepatitis B virus infection.
    Kamiya N
    J Antimicrob Chemother; 2003 May; 51(5):1085-9. PubMed ID: 12697634
    [No Abstract]   [Full Text] [Related]  

  • 11. Endpoints for clinical trials on treatment of hepatitis C.
    Kang H; Lok AS
    J Hepatol; 2006 Oct; 45(4):473-5. PubMed ID: 16901577
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.
    Lok AS; Zoulim F; Locarnini S; Bartholomeusz A; Ghany MG; Pawlotsky JM; Liaw YF; Mizokami M; Kuiken C;
    Hepatology; 2007 Jul; 46(1):254-65. PubMed ID: 17596850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel treatment options for hepatitis B virus infection.
    Kumar R; Agrawal B
    Curr Opin Investig Drugs; 2004 Feb; 5(2):171-8. PubMed ID: 15043391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial results of new therapies for HBV: implications for treatment guidelines.
    Gish RG
    Semin Liver Dis; 2005; 25 Suppl 1():29-39. PubMed ID: 16103979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing studies to evaluate anti-hepatitis B virus therapies: from the perspective of studies for the registration of pharmaceutical products.
    Murray AB
    Methods Mol Med; 2004; 96():445-56. PubMed ID: 14762286
    [No Abstract]   [Full Text] [Related]  

  • 16. The implications of antiviral drugs with activity against hepatitis B virus and HIV.
    Bottecchia M; Garcia-Samaniego J; Soriano V
    Curr Opin Infect Dis; 2007 Dec; 20(6):621-8. PubMed ID: 17975413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug insight: Nucleoside and nucleotide analog inhibitors for hepatitis B.
    Fung SK; Lok AS
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):90-7. PubMed ID: 16265070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The antiviral therapy of chronic hepatitis B].
    Kokoreva LN; Zmyzgova AV
    Ter Arkh; 1995; 67(2):65-8. PubMed ID: 7536961
    [No Abstract]   [Full Text] [Related]  

  • 19. [New advances in the treatment of chronic hepatitis B: position of entecavir].
    Olaso V
    Rev Esp Quimioter; 2007 Sep; 20(3):259-60. PubMed ID: 18080023
    [No Abstract]   [Full Text] [Related]  

  • 20. [Entecavir - options and obstacles of an effective treatment for chronic hepatitis B].
    Cornberg M; Manns MP
    Dtsch Med Wochenschr; 2010 Jan; 135(1-2):32-7. PubMed ID: 20024882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.